Atrial fibrillation begets heart failure and vice versa: Temporal associations and differences in preserved versus reduced ejection fraction

Circulation

Volumn 133, Issue 5, 2016, Pages 484-492

  Santhanakrishnan, Rajalakshmi ^a   Wang, Na ^b   Larson, Martin G ^b,c   Magnani, Jared W ^a,b   McManus, David D ^d   Lubitz, Steven A ^e,f   Ellinor, Patrick T ^e,f   Cheng, Susan ^b,g   Vasan, Ramachandran S ^a,b   Lee, Douglas S ^h   Wang, Thomas J ⁱ   Levy, Daniel ^b,j   Benjamin, Emelia J ^a,b,d   Ho, Jennifer E ^b,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c Boston University   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ VANDERBILT UNIVERSITY   (United States)

^j NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

atrial fibrillation; epidemiology; heart failure; mortality; ventricular function, left

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; COHORT ANALYSIS; COMPARATIVE STUDY; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STROKE VOLUME;

EID: 84956824866     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.018614     Document Type: Article

References (44)

1. Braunwald E., Shattuck lecture: cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997 337 1360 1369. doi: 10.1056/NEJM199711063371906.
2. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015 131 e29 e322. doi: 10.1161/CIR.0000000000000152.
3. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X., Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol 2013 112 1142 1147. doi: 10.1016/j.amjcard.2013.05.063.
4. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D., Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993 88 107 115
5. McManus DD, Hsu G, Sung SH, Saczynski JS, Smith DH, Magid DJ, Gurwitz JH, Goldberg RJ, Go AS, Cardiovascular Research Network PRESERVE Study Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc 2013 2 e005694. doi: 10.1161/JAHA.112.005694.
6. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW., Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials: Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998 32 695 703
7. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ., Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003 107 2920 2925. doi: 10.1161/01.CIR.0000072767.89944.6E.
8. Eapen ZJ, Greiner MA, Fonarow GC, Yuan Z, Mills RM, Hernandez AF, Curtis LH., Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction. Am Heart J 2014 167 369 375.e2. doi: 10.1016/j.ahj.2013.12.001.
9. Melenovsky V, Hwang SJ, Redfield MM, Zakeri R, Lin G, Borlaug BA., Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Circ Heart Fail 2015 8 295 303. doi: 10.1161/CIRCHEARTFAILURE.114.001667.
10. Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA, CHARM Investigators Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 2006 47 1997 2004. doi: 10.1016/j.jacc.2006.01.060.
11. Cheng M, Lu X, Huang J, Zhang J, Zhang S, Gu D., The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: insights from a meta-Analysis. Eur J Heart Fail 2014 16 1317 1322. doi: 10.1002/ejhf.187.
12. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP., An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 1979 110 281 290
13. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP., Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990 81 815 820
14. Gaynor JJ, Feuer EJ, Tan CC, Wu DH, Little CR, Straus DJ, Clarkson BD, Brennan MF., On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc 1993 88 400 409
15. Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Soliman EZ, Stricker BH, Gudnason V, Heckbert SR, Benjamin EJ., Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc 2013 2 e000102. doi: 10.1161/JAHA.112.000102.
16. Lin DY, Wei LJ., The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989 84 1074 78
17. Lunn M, McNeil D., Applying Cox regression to competing risks. Biometrics 1995 51 524 532
18. Lip GY, Halperin JL., Improving stroke risk stratification in atrial fibrillation. Am J Med 2010 123 484 488. doi: 10.1016/j.amjmed.2009.12.013.
19. Piccini JP, Hammill BG, Sinner MF, Hernandez AF, Walkey AJ, Benjamin EJ, Curtis LH, Heckbert SR., Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. Eur Heart J 2014 35 250 256. doi: 10.1093/eurheartj/eht483.
20. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS., Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003 108 977 982. doi: 10.1161/01.CIR.0000085166.44904.79.
21. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D., 50 Year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 2015 386 154 162. doi: 10.1016/S0140-6736(14)61774-8.
22. Linssen GC, Rienstra M, Jaarsma T, Voors AA, van Gelder IC, Hillege HL, van Veldhuisen DJ., Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 2011 13 1111 1120. doi: 10.1093/eurjhf/hfr066.
23. Zakeri R, Chamberlain AM, Roger VL, Redfield MM., Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation 2013 128 1085 1093. doi: 10.1161/CIRCULATIONAHA.113.001475.
24. Rusinaru D, Leborgne L, Peltier M, Tribouilloy C., Effect of atrial fibrillation on long-Term survival in patients hospitalised for heart failure with preserved ejection fraction. Eur J Heart Fail 2008 10 566 572. doi: 10.1016/j.ejheart.2008.04.002.
25. Pedersen OD, Søndergaard P, Nielsen T, Nielsen SJ, Nielsen ES, Falstie-Jensen N, Nielsen I, Køber L, Burchardt H, Seibaek M, Torp-Pedersen C, DIAMOND Study Group Investigators Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure. Eur Heart J 2006 27 2866 2870. doi: 10.1093/eurheartj/ehl359.
26. Ahmed MI, White M, Ekundayo OJ, Love TE, Aban I, Liu B, Aronow WS, Ahmed A., A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study. Eur Heart J 2009 30 2029 2037. doi: 10.1093/eurheartj/ehp222.
27. Mahoney P, Kimmel S, DeNofrio D, Wahl P, Loh E., Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol 1999 83 1544 1547
28. Corell P, Gustafsson F, Schou M, Markenvard J, Nielsen T, Hildebrandt P., Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007 9 258 265. doi: 10.1016/j.ejheart.2006.08.004.
29. Maisel WH, Stevenson LW., Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003 91 2D 8D
30. Tsang TS, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, Oh JK, Leibson C, Montgomery SC, Seward JB., Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002 40 1636 1644
31. Rosenberg MA, Gottdiener JS, Heckbert SR, Mukamal KJ., Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J 2012 33 904 912. doi: 10.1093/eurheartj/ehr378.
32. Everett TH 4th, Olgin JE., Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 2007 4 suppl S24 S27. doi: 10.1016/j.hrthm.2006.12.040.
33. Pedersen OD, Bagger H, Keller N, Marchant B, Køber L, Torp-Pedersen C., Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) substudy. Circulation 2001 104 292 296
34. Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, Escher F, von Schlippenbach J, Skurk C, Steendijk P, Riad A, Poller W, Schultheiss HP, Tschöpe C., Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 2011 4 44 52. doi: 10.1161/CIRCHEARTFAILURE.109.931451.
35. Andersen MJ, Borlaug BA., Heart failure with preserved ejection fraction: current understandings and challenges. Curr Cardiol Rep 2014 16 501. doi: 10.1007/s11886-014-0501-8.
36. Mohammed SF, Hussain S, Mirzoyev SA, Edwards WD, Maleszewski JJ, Redfield MM., Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation 2015 131 550 559. doi: 10.1161/CIRCULATIONAHA.114.009625.
37. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, Atrial Fibrillation and Congestive Heart Failure Investigators Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008 358 2667 2677. doi: 10.1056/NEJMoa0708789.
38. Paulus WJ, Tschöpe C., A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013 62 263 271. doi: 10.1016/j.jacc.2013.02.092.
39. Phan TT, Abozguia K, Shivu GN, Ahmed I, Leyva F, Patel K, Frenneaux M., Increased atrial contribution to left ventricular filling compensates for impaired early filling during exercise in heart failure with preserved ejection fraction. J Card Fail 2009 15 890 897. doi: 10.1016/j.cardfail.2009.06.440.
40. Zakeri R, Borlaug BA, McNulty SE, Mohammed SF, Lewis GD, Semigran MJ, Deswal A, LeWinter M, Hernandez AF, Braunwald E, Redfield MM., Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail 2014 7 123 130. doi: 10.1161/CIRCHEARTFAILURE.113.000568.
41. Bavishi C, Khan AR, Ather S., Digoxin in patients with atrial fibrillation and heart failure: a meta-Analysis. Int J Cardiol 2015 188 99 101. doi: 10.1016/j.ijcard.2015.04.031.
42. Agarwal SK, Soliman EZ, Ambrose M, Prineas RJ, Folsom AR., Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2009 158 111 117
43. Bibbins-Domingo K, Pletcher MJ, Lin F, Vittinghoff E, Gardin JM, Arynchyn A, Lewis CE, Williams OD, Hulley SB., Racial differences in incident heart failure among young adults. N Engl J Med 2009 360 1179 1190. doi: 10.1056/NEJMoa0807265.
44. Schnabel RB, Rienstra M, Sullivan LM, Sun JX, Moser CB, Levy D, Pencina MJ, Fontes JD, Magnani JW, McManus DD, Lubitz SA, Tadros TM, Wang TJ, Ellinor PT, Vasan RS, Benjamin EJ., Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur J Heart Fail 2013 15 843 849. doi: 10.1093/eurjhf/hft041.